interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Drug shortage outlook › Methylprednisolone Acetate

Shortage outlook · all drugs · read October 2026

How long has Methylprednisolone Acetate been on the FDA shortage list?

Methylprednisolone Acetate has been on the FDA shortage list for 4 years and 10 months. 54 of the 397 listings measured since 2014 lasted at least that long. Of the 54 past listings that reached the same age, 88% were still listed 6 months later (48 listings measured) and 75% were still listed 12 months later (37 listings measured). These are counts of listings, not a forecast.

Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.

Not medical advice. A listing is what the FDA published, not a measure of what your pharmacy can supply. Do not use this page to decide whether to start, stop or change a medicine. Ask your pharmacist or prescriber, and see FDA drug shortage information for current notices.
Methylprednisolone Acetateon the FDA shortage list now
58months listed

Methylprednisolone Acetate has been on the FDA shortage list for 4 years and 10 months (January 2022 to October 2026).

  1. 54 of the 397 listings measured since 2014 lasted at least that long.
  2. Of the 54 past listings that reached the same age, 88% were still listed 6 months later (48 listings measured) and 75% were still listed 12 months later (37 listings measured).
  3. None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.

The listing history, to scale

  1. Methylprednisolone Acetate InjectionListed since January 2022 · 4 years and 10 months

What past listings of this age did

Of past listings that had already run 4 years and 10 months, how many were still listed later?

After 6 more months88%48 listings measured
After 12 more months75%37 listings measured
After 24 more monthstoo few listings to show a share23 listings measured

What the FDA list says about it today

23presentations listed
5companies
15 December 2021first posted

Reasons companies gave: demand increase for the drug (7), other (7) and shortage of an active ingredient (2); 7 of 23 gave none. FDA category: Rheumatology.

Company by company

Of 23 presentations, the companies reported 7 available, 8 with limited availability and 8 unavailable. This is each company's own report to the FDA, with the date of its last update.

FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.

Where can you go from this result?

This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.

To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.